(Q33974370)

30 July 2017

title

CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma (English)

1 reference

30 July 2017

0 references

Linni Fan

1

1 reference

30 July 2017

Furong He

2

1 reference

30 July 2017

Hongxiang Liu

3

1 reference

30 July 2017

Jin Zhu

4

1 reference

30 July 2017

Yixiong Liu

5

1 reference

30 July 2017

Zhiyong Yin

6

1 reference

30 July 2017

Lu Wang

7

1 reference

30 July 2017

Ying Guo

8

1 reference

30 July 2017

Zhe Wang

9

1 reference

30 July 2017

Qingguo Yan

10

1 reference

30 July 2017

Gaosheng Huang

11

1 reference

30 July 2017

language of work or name

English

0 references

publication date

29 July 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

page(s)

320

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-320

30 July 2017

exact match

0 references

cites work

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Exploring the origins of the normal prostate and prostate cancer stem cell

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

CD133: molecule of the moment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Differential expression of Prominin-1 (CD133) and Prominin-2 in major cephalic exocrine glands of adult mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

CD133+ renal progenitor cells contribute to tumor angiogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Identification and expansion of human colon-cancer-initiating cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Stem cells and cancer: an intimate relationship.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Focus on molecules: prominin-1 (CD133).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Prospective identification of tumorigenic prostate cancer stem cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Identification of human brain tumour initiating cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Identification of a cancer stem cell in human brain tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Prominin: a story of cholesterol, plasma membrane protrusions and human pathology.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Direct isolation of human central nervous system stem cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

AC133, a novel marker for human hematopoietic stem and progenitor cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161038

CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-320

CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-320

Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-320

Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-320

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-320

Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21798073

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21798073

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21798073

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-11-320

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference